Fox R, Arnold DL Bar-Or A, et al. Effects of siponimod on MRI outcomes in patients with secondary progressive multiple sclerosis: results of the phase 3 EXPAND study. ECTRIMS 2017, 129.
Klinisch relevante pathologie bij zeer vroege MS al aantoonbaar
nov 2020 | Multipele Sclerose